David Anderson
Chief Tech/Sci/R&D Officer presso VBI VACCINES INC.
Patrimonio netto: 2 979 $ in data 31/03/2024
Profilo
David Evander Anderson was the founder of Variation Biotechnologies (US), Inc. founded in 2001 where he held the title of Vice President-Immunology & Research.
He is also the founder of Variation Biotechnologies, Inc. (Canada).
Currently, Dr. Anderson holds the position of Chief Scientific Officer at VBI Vaccines, Inc. since 2016 and at VBI Vaccines (Delaware), Inc. since 2015.
Previously, he worked as an Assistant Professor at Harvard Medical School in 2009 and as the Chief Scientific Officer & Senior VP-Research at VBI Vaccines, Inc. Dr. Anderson received his doctorate degree from Harvard University in 1999 and his undergraduate degree from the University of California, Davis.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
VBI VACCINES, INC.
0.02% | 27/07/2023 | 4 940 ( 0.02% ) | 2 979 $ | 31/03/2024 |
Posizioni attive di David Anderson
Società | Posizione | Inizio |
---|---|---|
VBI VACCINES INC. | Chief Tech/Sci/R&D Officer | 06/05/2016 |
VBI Vaccines (Delaware), Inc.
VBI Vaccines (Delaware), Inc. BiotechnologyHealth Technology Part of VBI Vaccines, Inc., VBI Vaccines (Delaware), Inc. develops biopharmaceuticals. Jeffrey R. Baxter has been the CEO of the American company since 2014. | Chief Tech/Sci/R&D Officer | 01/08/2015 |
Precedenti posizioni note di David Anderson
Società | Posizione | Fine |
---|---|---|
Harvard Medical School | Corporate Officer/Principal | 01/02/2009 |
Variation Biotechnologies, Inc. (Canada)
Variation Biotechnologies, Inc. (Canada) BiotechnologyHealth Technology Variation Biotechnologies, Inc. (Canada) is a Canadian company that was founded by David Evander Anderson and is part of VBI Vaccines, Inc. The private company is based in Ottawa, Canada and engages in the manufacture of vaccines. | Founder | - |
VBI VACCINES INC | Chief Tech/Sci/R&D Officer | - |
Variation Biotechnologies (US), Inc.
Variation Biotechnologies (US), Inc. BiotechnologyHealth Technology Variation Biotechnologies (US), Inc. develops and manufactures vaccines for infectious diseases. It is dedicated to the innovative formulation, development and delivery of safe and effective vaccines that expand and enhance vaccine protection in both established and emerging markets. The company was founded by David E. Anderson and Adam Buckley in 2001 and is headquartered in Boston, MA. | Founder | - |
Formazione di David Anderson
Harvard University | Doctorate Degree |
University of California, Davis | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
VBI VACCINES INC. | Health Technology |
Aziende private | 4 |
---|---|
Variation Biotechnologies (US), Inc.
Variation Biotechnologies (US), Inc. BiotechnologyHealth Technology Variation Biotechnologies (US), Inc. develops and manufactures vaccines for infectious diseases. It is dedicated to the innovative formulation, development and delivery of safe and effective vaccines that expand and enhance vaccine protection in both established and emerging markets. The company was founded by David E. Anderson and Adam Buckley in 2001 and is headquartered in Boston, MA. | Health Technology |
Variation Biotechnologies, Inc. (Canada)
Variation Biotechnologies, Inc. (Canada) BiotechnologyHealth Technology Variation Biotechnologies, Inc. (Canada) is a Canadian company that was founded by David Evander Anderson and is part of VBI Vaccines, Inc. The private company is based in Ottawa, Canada and engages in the manufacture of vaccines. | Health Technology |
VBI Vaccines (Delaware), Inc.
VBI Vaccines (Delaware), Inc. BiotechnologyHealth Technology Part of VBI Vaccines, Inc., VBI Vaccines (Delaware), Inc. develops biopharmaceuticals. Jeffrey R. Baxter has been the CEO of the American company since 2014. | Health Technology |
VBI Vaccines, Inc. /Old/
VBI Vaccines, Inc. /Old/ BiotechnologyHealth Technology VBI Vaccines, Inc. is a biopharmaceutical company. It engages in the development of eVLP vaccine platform for the design of (e) virus-like-particle vaccines that closely mimic the target virus. The company also involves in the development of thermostable technology that enables the development of vaccines and biologics that can withstand storage or shipment at constantly fluctuating temperatures. VBI Vaccines was founded on July 25, 2014 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- David Anderson